𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dual targeting of EGFR and HER-2 in colon cancer cell lines

✍ Scribed by Efstathia Giannopoulou; Anna Antonacopoulou; Konstantina Floratou; Athanasios G. Papavassiliou; Haralabos P. Kalofonos

Publisher
Springer
Year
2008
Tongue
English
Weight
484 KB
Volume
63
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Targeting of substance P induces cancer
Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2
✍ Cristina Mayordomo; Susana GarcΓ­a-Recio; Elisabet Ametller; Patricia FernΓ‘ndez-N πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 699 KB

## Abstract NK1 is a tachykinin receptor highly relevant to tumorigenesis and metastasis development in breast cancer and other carcinomas. Despite the substantial efforts done to develop potent NK1 receptor antagonists, none of these antagonists had shown good antitumor activity in clinical trials

The dual EGFR/HER-2 tyrosine kinase inhi
The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38
✍ Melissa J. LaBonte; Philipp C. Manegold; Peter M. Wilson; Will Fazzone; Stan G. πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 482 KB

## Abstract Members of the human epidermal receptor (HER) family are frequently associated with aggressive disease and poor prognosis in multiple malignancies. Lapatinib is a dual tyrosine kinase inhibitor targeting the epidermal growth factor receptor (EGFR) and HER‐2. This study evaluated the the

Bispecific antibody targeting of doxorub
Bispecific antibody targeting of doxorubicin to carcinoembryonic antigen–expressing colon cancer cell lines in vitro and in vivo
✍ C.H.J. Ford; P.A. Osborne; B.G. Rego; A. Mathew πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 120 KB

A bispecific monoclonal antibody (BsMAb) recognising carcinoembryonic antigen (CEA) and doxorubicin (Dox) was used in colorimetric microcytotoxicity assays with 3 human colon cancer cell lines (COLO320DM, SKCO1 and LS174T) showing no, high or medium CEA expression, respectively. The IC50 values for

Lack of phospholipase A2 mutations in ne
Lack of phospholipase A2 mutations in neuroblastoma, melanoma and colon-cancer cell lines
✍ Frank G. Haluska; Carol Thiele; Alisa Goldstein; Hensin Tsao; Eric P. Benoit; Da πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 61 KB πŸ‘ 2 views

A candidate murine tumor-suppressor gene, Mom1, has been identified as the secretory phospholipase A2 (GDB nomenclature: PLA2G2A) gene. Evidence suggests that PLA2G2A functions as a tumor-suppressor because mice lacking PLA2G2A expression demonstrate increased colonic polyposis. The human homologue